Heidi Anderson1*, Taylor Patch2*, Pavan Reddy3*, Elliott Hagedorn3*, Owen J. Tamplin, PhD4, Daniel E. Bauer, M.D., Ph.D.5, Barry H. Paw, M.D., Ph.D.6, Dietmar Vestweber7*, Leonard I. Zon, M.D8, Stuart H. Orkin, M.D.9, George Q. Daley, MD, PhD10 and Dhvanit I. Shah, Ph.D.11,12
1Brigham and Women's Hospital, Harvard Medical School, Boston, MA
2Brigham and Women's Hospital, Boston, MA
3Boston Children's Hospital, Boston, MA
4Stem Cell Program and Division of Hematology/Oncology, Children's Hospital Boston, Boston, MA
5Pediatric Hematology-Oncology, Boston Children's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
6Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
7Max Plank Institute for Molecular Biomedicine, Muenster, Germany
8Stem Cell Program and Division of Hematology/Oncology, Howard Hughes Medical Institute, Boston Children's Hospital/Harvard Medical School, Boston, MA
9Department of Pediatric Oncology, Boston Children's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, HHMI, Boston, MA
10Hematology/Oncology, Boston Children's Hospital, Boston, MA
11Hematology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
12Harvard Stem Cell Institute, Cambridge, MA